2nd Quarter - Report
THE MCMANUS GROUP for TETRAPHASE PHARMACEUTICALS
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| CHASE M THOMAS New | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.